Maćkowiak M

Department of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology Polish Academy of Sciences, Smętna 12, 31-343, Kraków, Poland.

8 papers · 1 preprint · ORCID

ArticlePsilocybin

Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex.

Wawrzczak-Bargieła A, Jelonek-Kozioł M, Kumorek W +2

Europe PMC2026
ArticlePsilocybin

Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats.

Bysiek A, Szpręgiel I, Wojtas A +8

Europe PMC2026
ArticlePsilocybin

The effect of low-dose psilocybin on brain neurotransmission and rat behavior.

Bysiek A, Wojtas A, Szpręgiel I +3

Europe PMC2025
ArticlePsychedelics

Correction: Psychedelics action and schizophrenia.

Maćkowiak M

Europe PMC2024
ArticlePsilocybin

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +2

Europe PMC2023
ArticlePsychedelics

Psychedelics action and schizophrenia.

Maćkowiak M

Europe PMC2023
PreprintPsilocybin

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +2

Europe PMC2023
ArticlePsilocybin

Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.

Wojtas A, Bysiek A, Wawrzczak-Bargiela A +5

Europe PMC2022
ArticlePsychedelics

Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe.

Herian M, Wojtas A, Maćkowiak M +5

Europe PMC2022